Talecris' comprehensive safety and quality management programs have ensured that our albumin products continue to exhibit an excellent safety record. The breadth and depth of these measures demonstrate Talecris Biotherapeutics' ongoing commitment to excipient customers who rely on our albumin products.
Talecris Albumin Products have no documented pathogen transmission in over six decades because of methods that include:
 |
 |
Regular inspection of plasma donor centers, three to six times each year
|
|
Strict screening of plasma donors
|
|
Complete donor documentation, including full medical examination and history
|
|
State-of-the-art test methods, including PCR testing for viruses and
Western blot assay (PDF)
for prion clearance
|
|
Four distinct effective steps that complement each other in their mechanism of virus reduction
|
|
Continuous quality control
|
|
|